Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer

The drive towards hypofractionated prostate radiotherapy is motivated by a low alpha/beta ratio for prostate cancer (1 to 3 Gy) compared to surrounding organs at risk, implying an improved therapeutic ratio with increasing dose per fraction. Early evidence from studies of ultrahypofractionated (UHF)...

Full description

Bibliographic Details
Main Authors: Jonathan Mohajer, Alex Dunlop, Adam Mitchell, Edmund Goodwin, Simeon Nill, Uwe Oelfke, Alison Tree
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820300859